NeoVirTech
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
327 4,005Activities
Technologies
Entity types
Location
1 Pl. Pierre Potier, 31100 Toulouse, France
Toulouse
France
Employees
Scale: 2-10
Estimated: 6
SIREN
800203739Engaged corporates
13
2 6Added in Motherbase
3 years, 3 months ago
biotech Value proposition
Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes
NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. The company has been highlighted in the Top10 drug discovery companies, Europe, 2019 by the PharmaTechOutlook Magazine. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging.
At NeoVirTech, we believe everyone can have access to state-of-the-art virology techniques. We are focusing our activities on antiviral discovery, study of oncolytic and gene therapy products and quantification of disinfection procedures (physical, chemical, radiative) on a strong collection of pathogenous viruses impacting the human, animal and biodefence market. We work in classical BSL2 lab (Herpes, adenovirus, ...), BSL2+ level (influenza H1N1, RSV, rhinovirus) to BSL3 confinement (highly pathogenous influenza, SARS-CoV-2).
With our ANCHOR technology, we can directly visualize virus infection and replication in living cells without fixation, extraction or reagents. Customers use our service to identify rapidly and efficiently new antiviral molecules, calibrate disinfection devices, investigate oncolytic virus behavior or understand the biology of gene therapy vectors.
Our technologies relies on state off the art microscopy platform, providing our customers qualitative images for communication and marketing operations.
If viruses is of your concern, contact us:
contact@neovirtech.com
More informations: www.neovirtech.com
Virology, High content screening, Custom design, fluorescence microscopy, Anti-Viral compounds, oncolytic virus, gene therapy, vaccine, imaging, biotech, high content imaging, and drug screeningOriginal language
Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes
NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging.
NVT possesses the exclusive worldwide license for the ANCHORTM technology that allows fast and efficient screening campaign. Our next generation technology can be applied in antiviral screening, gene delivery and oncolytic virotherapies. The beauty and quality of the data we generate are also a tremendous asset for communication and marketing.
Our customers include academics centers, biotechnology companies and large pharmaceutical companies. Our offer is specifically designed for the anti-infectious, gene therapies, vaccines and oncolytic virotherapies market in human and animal health.
NeoVirTech - Antiviral screening & discovery
Next generation technology for virus/viral vector imaging applied in antiviral screening, gene delivery and oncolytic virotherapies
https://neovirtech.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Réseau SATT | Other 5 Oct 2024 | | |
 | Gouvernement | Other 5 Oct 2024 | | |
 Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Other 5 Oct 2024 | | |
 PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 5 Oct 2024 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 5 Oct 2024 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 5 Oct 2024 | | |
 | Toulouse Tech Transfer | Other 8 Feb 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 8 Feb 2024 | | |
 | Santé publique France | Other 7 Nov 2022 | | |
 | Ministère de la Défense | Other 22 Sep 2024 | | |